Friday, June 10, 2022

< + > Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

No comments:

Post a Comment

< + > Is it a Tech Problem or a Policy Problem in Value-Based Care?

We’ve been working to move towards value-based care for a while now, but there are still some kinks we need to work out to have it run the w...